Welcome to Eris Lifesciences Private Limited

Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and a leading player in the domestic branded formulation market. Ranked #20 in the IPM, Eris has established a leading presence in its core cardio-metabolic franchise in just 17 years from inception. Eris is also successfully diversifying its business with 4 emerging therapies (Dermatology, Neuropsychiatry, Women’s Health and Nephrology) accounting for 29% of its revenue. We began our journey 17 years ago in 2007 with the vision to make a meaningful impact in the management of chronic lifestyle-related diseases. Today, Chronic and Sub-chronic therapies account for ~ 86% of our revenue, and our product range spans ~ 90% of India’s Rs. 55,000+ crore chronic care market.